Terminology Service for NFDI4Health
All terms in BAO
| Label | Id | Description |
|---|---|---|
| fungal infectious disease | DOID_1564 | [A disease by infectious agent that results_in infection, has_material_basis_in Fungi, which pass the resistance barriers of the human or animal body.] |
| subcutaneous mycosis | DOID_0050135 | [A fungal infectious disease that results_in infection located_in skin or located_in subcutaneous tissue, has_material_basis_in Fungi, which penetrate the dermis or even deeper during or after a skin trauma.] |
| renal pelvis carcinoma | DOID_4919 | |
| cutaneous mycosis | DOID_0050134 | [A fungal infectious disease that results_in infection of the keratinized layers located_in skin, located_in hair or located_in nail, which extends deeper into the epidermis, has_material_basis_in Fungi and results_in_formation_of skin lesions.] |
| EC 3.4.21.37 (leukocyte elastase) inhibitor | CHEBI_64922 | |
| EC 6.5.1.1 [DNA ligase (ATP)] inhibitor | CHEBI_64920 | |
| EC 6.5.1.* (DNA/RNA repair enzymes) inhibitor | CHEBI_76827 | |
| serine protease inhibitor | CHEBI_64926 | |
| HeLa cell | CLO_0003684 | |
| hepatitis C protease inhibitor | CHEBI_64924 | |
| subacute lymphocytic thyroiditis | DOID_7187 | |
| thyroiditis | DOID_7166 | |
| autoimmune thyroiditis | DOID_7188 | [An autoimmune disease of endocrine system that involves inflammation located_in thyroid gland caused by the immune system reacting against its own tissues.] |
| AP-1 antagonist | CHEBI_67199 | |
| blood serum | UBERON_0001977 | [The portion of blood plasma that excludes clotting factors.] |
| carboxylic acid protecting group | CHEBI_52943 | |
| protecting group | CHEBI_51087 | |
| sodium channel blocker | CHEBI_38633 | |
| phosphate protecting group | CHEBI_52941 | |
| Aspergillus metabolite | CHEBI_76956 |